Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Filings indexed 1,118 across all filing types
Latest filing 2024-05-23 Report Publication Anno…
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document contains a letter dated 23rd May 2024 addressed to stock exchanges regarding the publication of financial results for the quarter and year ended 31st March 2024. It mentions Regulation 47 of the Listing Regulations and includes copies of financial results published in newspapers. The document is a notification or announcement about the financial results being published, not the full financial report itself. The length is about 15,000 characters, but the content is primarily an announcement of the results publication, not the detailed report or financial statements. Therefore, according to the MENU VS MEAL RULE, this is a Report Publication Announcement (RPA).
2024-05-23 English
Pl. find enclosed newspaper publication of financial results for the quarter and year ended 31st March 2024 u/r. 47 of LODR
Regulatory Filings
2024-05-23 English
Pl. find enclosed Annual Secretarial Compliance report u/r. 24A(2) of LODR.
Regulatory Filings
2024-05-23 English
Outcome of Board Meeting
Annual Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors of Unichem Laboratories Limited dated 22nd May 2024. It includes approval and disclosure of unaudited financial results for the quarter ended 31st March 2024 and audited financial results for the year ended 31st March 2024. The document contains consolidated and standalone financial statements, including statement of assets and liabilities, cash flow statement, auditor's report with unmodified opinion, and notes explaining accounting policies, exceptional items, and segment information. The presence of full financial data, audit opinion, and comprehensive financial disclosures indicates this is a full annual financial report. The document is not merely an announcement or a brief summary but contains substantive financial data and analysis. Therefore, it fits the definition of an Annual Report (10-K equivalent).
2024-05-22 English
PFA herewith financial results for the quarter and year ended 31st March 2024
Regulatory Filings
2024-05-22 English
Outcome of Board Meeting
Regulatory Filings
2024-05-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.